Haematology Journal Articles and Videos
Whole-body Vibration Training as a Supportive Therapy During Allogeneic Haematopoietic Stem Cell Transplantation – A...
European Oncology and Haematology. 2018;14(1):33–39 DOI: https://doi.org/10.17925/EOH.2018.14.1.33
Finding and Treating Gaucher Disease Type 1 – The Role of the Haematologist
European Oncology & Haematology. 2018;14(1):50–56 DOI: https://doi.org/10.17925/EOH.2018.14.1.50
Advancing Our Clinical Perspectives in Haematology – What is Your Approach?
European Oncology & Haematology, 2016;12(Suppl 1):i–viii
Optimising the Use of Ruxolitinib in Inadequately Controlled Polycythaemia Vera
European Oncology & Haematology, 2016;12(2):81–6 DOI: https://doi.org/10.17925/EOH.2016.12.02.81
Professor of Hematology and head of the Hematology and cellular therapy Department at the Saint-Antoine Hospital and University Pierre & Marie Curie (Paris, France).
Professor Mohty obtained his medical degree from the University of Montpellier, France, and his PhD from the University of Marseille, France. He also undertook post-doctoral work at the Hematology Department, Imperial College, Hammersmith Hospital, London, UK.
Professor Mohty is also head of a translational research team (INSERM team N°7) at the Saint-Antoine Research centre in Paris and his research is focused on the pathophysiology and immunobiology of normal and pathological antigen-presenting cells, especially the impact of novel immunomodulatory agents such as proteasome inhibitors, IMiDs and hypomethylating agents. He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of acute leukemia and multiple myeloma.
Professor Mohty is currently president of the European Society for Blood and Marrow Transplantation (EBMT). He serves on the board of the EBMT, and the “Intergroupe Francophone du Myelome” (IFM). He is a member of the American Society of Hematology, American Society for Clinical Oncology, American Society for Blood and Marrow Transplantation, European Hematology Association, International Society for Experimental Hematology, and EBMT.
Professor Mohty has published more than 430 peer-reviewed articles in the field of stem cell transplantation, leukemia and myeloma, in different hematology and immunology journals. He also serves as Editor-in-Chief of the journal Bone Marrow Transplantation, as Associate Editor for Leukemia, European Journal of Haematology and Blood Cancer Journal, as member of the editorial board of Haematologica, and as a regular reviewer in different immunology, hematology, and cancer journals such as Blood, The Lancet, and Nature Reviews.
Guest professor and senior consultant at the Center for Thrombosis and Hemostasis at the University Medical Center, Mainz, Germany.
Bernhard Lämmle, M.D., was Professor of Hematology and Director of the Department of Hematology and the Central Hematology Laboratory at the University Hospital of Bern, Switzerland, from 1989 until his retirement in July 2013. He then became a guest professor and senior consultant at the Center for Thrombosis and Hemostasis at the University Medical Center, Mainz, Germany. His scientific interest concerns various clinical and laboratory aspects of hematology, hemostasis and thrombosis with a special focus on thrombotic thrombocytopenic purpura and the metalloprotease ADAMTS13. Bernhard Lämmle has coauthored more than 270 publications and held many educational and state-of-the-art lectures at international congresses.